Skip to main content
. 2023 Aug 10;34(10):1733–1751. doi: 10.1681/ASN.0000000000000189

Figure 2.

Figure 2

Frequency of peripheral blood leukocytes during the study period. Percentages of CD4+ T cells (A), CD8+ T cells (B), B cells (C), Lin−HLADR+ dendritic cells (D), monocytes (E), cytotoxic NK cells (F), and natural killer T cells (G) within CD45+ peripheral blood leukocytes in participants randomized to ORBCEL-M or placebo during the follow-up. Values are expressed as median (IQR). *P < 0.05 between the ORBCEL-M and placebo groups (ANCOVA). §P < 0.05 versus preinfusion in the group (Wilcoxon test). Lin−: CD3, CD14, CD16, CD19, CD20, and CD56.